Read more about it
5 stories about Mori Arkin
Exalenz Bioscience Acquired for $49M
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
Anti-Acne Drug Developer Plans Nasdaq IPO
Tag does not exist. Please try again.